![Frank P. Holladay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Frank P.
Holladay is the founder of TVAX Biomedical I LLC and TVAX Biomedical, Inc. He held the title of Chief Medical Officer at both companies, which were founded in 2004 and 2011, respectively.
Holladay received a doctorate degree from Creighton University and an undergraduate degree from the University of California, Berkeley.
Aktive Positionen von Frank P. Holladay
Unternehmen | Position | Beginn |
---|---|---|
TVAX BIOM | Gründer | 14.07.2011 |
TVAX Biomedical I LLC | Gründer | 01.11.2004 |
Ausbildung von Frank P. Holladay
University of California, Berkeley | Undergraduate Degree |
Creighton University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
TVAX Biomedical, Inc.
![]() TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
TVAX Biomedical I LLC |